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Lugdunomycin, an Angucycline-Derived Molecule with
Unprecedented Chemical Architecture
Changsheng Wu, Helga U. van der Heul, Alexey V. Melnik, Jens Lgbben, Pieter C. Dorrestein,
Adriaan J. Minnaard, Young Hae Choi, and Gilles P. van Wezel*
Abstract: The angucyclines form the largest family of poly-
cyclic aromatic polyketides, and have been studied extensively.
Herein, we report the discovery of lugdunomycin, an angucy-
cline-derived polyketide, produced by Streptomyces species
QL37. Lugdunomycin has unique structural characteristics,
including a heptacyclic ring system, a spiroatom, two all-
carbon stereocenters, and a benzaza-[4,3,3]propellane motif.
Considering the structural novelty, we propose that lugduno-
mycin represents a novel subclass of aromatic polyketides.
Metabolomics, combined with MS-based molecular network-
ing analysis of Streptomyces sp. QL37, elucidated 24 other
rearranged and non-rearranged angucyclines, 11 of which were
previously undescribed. A biosynthetic route for the lugduno-
mycin and limamycins is also proposed. This work demon-
strates that revisiting well-known compound families and their
producer strains still is a promising approach for drug
discovery.
Actinobacteria are Gram-positive, and often filamentous,
bacteria that are a major source of bioactive natural
products,[1, 2] and most of these are produced by actinomycetes
of the genus Streptomyces.[2,3]Despite the increasing difficulty
to isolate new molecules, the biosynthetic potential of actino-
mycetes is far from exhausted.[4, 5] Many such molecules are
most likely specified by biosynthetic gene clusters (BGCs)
that are poorly expressed in the laboratory, generally referred
to as cryptic gene clusters.[6,7] However, novel molecules have
also been identified via the “one strain—many compounds”
(OSMAC) strategy,[8] which further supports the notion that
actinobacteria harbor significant unexplored chemical diver-
sity. Angucyclines and angucyclinones,[9] which bear an
unsymmetrically assembled benz[a]anthracene frame, repre-
sent the largest family of polycyclic aromatic polyketides from
actinomycetes, and exhibit a broad range of biological,
predominantly anticancer and antibacterial, activities.[9, 10]
The minimal polyketide synthase (PKS) forms the initial
angucycline or angucyclinone framework that is further
modified by a wide array of post-PKS tailoring enzymes.[9]
Herein, we report the discovery of a novel angucycline-
derived compound, lugdunomycin (1, Figure 1) with a striking
benzaza[4,3,3]propellane-6-spiro-2’-2H-naphtho[1,8-bc]furan
backbone, found in Streptomyces sp. QL37. OSMAC, com-
bined with MS/MS-based molecular networking, character-
ized 24 other rearranged and non-rearranged angucyclines 2–
25 (Figure 1), 11 of which were new structures featuring
unique ring rearrangement, oxidation, reduction, and amida-
tion patterns. The new structural features, and in particular
the Baeyer–Villiger oxidative cleavage and expansion of the
C-ring of angucycline, further enrich the existing diversity of
angucycline- and/or angucyclinone-type natural products.
In our search for novel chemical diversity, seven strains
showing distinctive pigmentation were prioritized from our
actinomycete strain collection[11] because distinctive pigmen-
tation is a beacon for chemical diversity.[12] The actinomycetes
were grown in six different culture media, and their metab-
olomes were compared by thin-layer chromatography (TLC).
Of these, Streptomyces sp QL37 yielded a rich metabolic
profile, and this strain was therefore subjected to up-scale
(7.5 liter) on MM agar plates. Repeated chromatography of
the crude extract (2.3 g) resulted in compounds 1 (0.5 mg), 2
(27 mg), 6/7 (27 mg), 8 (3.4 mg), and 11 (1 mg).
The isolated colorless 1 was called lugdunomycin after
Lugdunum batavorum, the Latin name for the city of Leiden.
UHPLC-ToF-MS analysis of 1 identified an [M+H]+ peak at
m/z 474.1553, establishing its molecular composition as
C27H23NO7. The deduced chemical formula was corroborated
by the attached proton test (APT) that exhibited 27 carbons.
The three aromatic rings A, B, and D, were readily assigned
based on the proton-splitting pattern in the 1H NMR spec-
trum and COSY correlations (Supporting Information,
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Figure 1. Angucyclines isolated from Streptomyces sp. QL37. Lugdunomycin (1) is a novel angucycline derivative. All the previously undescribed
compounds are shown in red.
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Table S1 and Figure S1). Benzene rings A and B were fused
into a naphthalene system by sharing a double bond between
C-4a and C-8a, based on the HMBC correlations H-4/C-8a,
H-5/C-8a, H-4/C-5, H-5/C-4, and H-6/C-4a. Ring C was
identified by HMBC correlations from H-16 to C-10, C-14,
and C-15 of ring D. Key HMBC correlations, such as H-19/C-
17, H-19/C-21, H-20/C-17, and H-20/C-21, unequivocally
showed that the cyclopentanol ring F is joined to ring C by
sharing the bond between C-17 and C-21. Furthermore, H-18
and H-20 showed 3JCH HMBC correlations with two carbonyl
groups at dC 182.4, and 182.5, respectively, which indicated the
presence of another ring fused to two all-carbon stereocen-
ters,[13] C-17 and C-21, apart from rings C and F; these two
carbonyls are joined by a nitrogen atom in line with both the
molecular formula and the chemical shifts, consistent with
succinimide ring G. Consequently, rings D/C/F/G constituted
a benzaza[4,3,3]propellane motif. Ring systems A/B and D/C/
F/G are linked at spiroatom C-9, as established by key HMBC
correlations H-20/C-9, H-11/C-9, and H-6/C-9. An additional
five-membered furan ring (ring E) is formed to make a 2H-
naphtho[1,8-bc]furan module [7-methyl-2H-naphtho[1,8-
bc]furan-3-ol] to join the whole structure and fit in the
molecular formula. Taken together, the benzaza-
[4,3,3]propellane skeleton is adorned with a spirocyclic 2H-
naphtho[1,8-bc]furan moiety and two all-carbon quaternary
centers embedded within five contiguous stereogenic carbons.
The benzaza[4,3,3]propellane-6-spiro-2’-2H-naphtho[1,8-
bc]furan architecture is unprecedented.
Single-crystal X-ray diffraction confirmed the structure of
lugdunomycin (1) (Supporting Information, Table S2). Crys-
tallization of 1 exhibited a centrosymmetric space group P42/
n, explicitly supporting a racemic mixture. The configurations
of five chiral centers in 1 were determined as 9R*, 16S*, 17R*,
19S*, and 21S* (Figure 2 and Supporting Information, Fig-
ure S2). The racemic nature of the obtained lugdunomycin
was also suggested by the measured optical rotation of zero.
To obtain insight into the diversity of angucycline-derived
molecules produced by Streptomyces sp. QL37, we performed
global natural products social (GNPS) molecular networking
using MS/MS profiles[14,15] and compared the output to the
GNPS database.[16] To ensure optimal chemical diversity,
Streptomyces sp. QL37 was fermented in 77 different culture
media (Supporting Information, Table S3), as described.[11]
MS/MS-based molecular networking of QL37 grown on R5+
0.8% peptone + 1% mannitol and MM + 0.5% mannitol +
1% glycerol presented the relatedness among metabolites
(Supporting Information, Figure S3), including the structur-
ally related angucyclines (Figure 1) and other families of
compounds (Supporting Information, Figure S5). This obser-
vation not only dereplicated the non-rearranged angucy-
clines 2, 6–8, and 11 isolated from MM medium (Supporting
Information, Figure S4), but also revealed many nitrogen-
containing angucyclines (Figure 3B). Especially, the subnet-
work for lugdunomycin identified a putative aldehyde
analogue of 1 with m/z 502 (Figure 3A).
Up-scale refermentation (20 L) of Streptomyces sp. QL37
in R5 medium followed by extensive systematic isolation, via
OSMAC[8] identified compounds 2–45, including unrear-
ranged benz[a]anthracene angucyclines (2–12), limamycins[17]
(13–19), emycins[17–19] (20, 21), naphthalenones (22, 23),
anthraquinones (24, 25, Figure 1), nucleosides (26–33), cyclo-
dipeptides (34–41), 4-quinolones (42, 43), vitamin K (44), and
quinazolinone (45, Supporting Information, Figure S5). Of
these, compounds 5, 9, 14–17, and 21–25 were new structures.
The NMR data assignments of new angucyclines are sum-
marized in Tables S4–S6 in the Supporting Information, and
the 2D NMR correlations (HMBC and COSY) are displayed
in Figure S1 in the Supporting Information. The 11 new
angucyclines featured, among others, unique ring cleavage
(ring A or C) and rearrangement (13–25), hydration of double
bond D12,12a (15, 16), nucleophilic addition of methanol to the
ketone at C-7 (14), epoxidation of double bond D6a,12b (5), N-
quaternary methylation (16), amidation (13–19, 24, and 25),
and reduction of the ketone at C-7 (20, 21). Though 14 is
likely an artifact due to the usage of methanol during
chromatographic isolation, all these new structures add
further chemical diversity to this important family of poly-
ketides.
In terms of bioactivity, an agar diffusion assay whereby
pure compound was spotted on filter on a lawn of the target
bacterium, showed that lugdunomycin had antimicrobial
activity against the Gram-positive Bacillus subtilis 168, but
not against the Gram-negative Escherichia coli K12 (not
shown). More extensive experiments are needed to assess the
bioactivity and mode of action of lugdunomycin.
Based on the structures of the identified molecules
(Figure 1), a biosynthetic route of rearranged limamycins
and/or non-rearranged angucyclines is proposed (Figure 4).
Versatile post-PKS oxidations are critical for the rearrange-
ment of the precursors 2 and/or 6. The cleavage at the C-1/12b
bond in the A-ring of 2 generates the tricyclic anthraquinone
scaffold in 24 and 25. Another pivotal Baeyer–Villiger
Figure 2. ORTEP drawing of the crystal structure of lugdunomycin. The
absolute configurations of the five chiral centers of lugdunomycin are
9R*, 16S*, 17R*, 19S*, and 21S*.
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oxidation at the C-6a/C-7 bond of the quinone ring C is
proposed to initiate the structural rearrangements of 2 and/or
6 to give compounds 13–23. The lactone intermediate 6a or
2a is susceptible to hydration resulting in lactone ring
opening, followed by the amidation at C-12 ketone to
introduce a nitrogen atom in 6c or 2c, which is cyclized to
form limamycins[17] 13–19 (Figure 4A). Alternatively, 2a
could go through an evolutionary pathway involved in
emycin biosynthesis,[18] whereby a reduction at the ketone
group of C-7 is essential to generate compounds 20 and 21.
The co-identification of compounds 2–25 in Streptomyces
sp. QL37 and elucidation of the biosynthetic pathway for the
nitrogen-containing limamycins shed light on the biosynthetic
logic of lugdunomycin (1, Figure 4B). We hypothesize that
the benzaza[4,3,3]propellane skeleton of lugdunomycin is
eventually constructed through a Diels–Alder [4+2] cyclo-
addition, and the diene and dienophile reagents for the Diels–
Alder reaction are provided by the limamycin and emycin
biosynthetic pathway, respectively. The putative limamy-
cin 15a is likely to go through a cascade of oxidative C@C
bond cleavage in the D-ring, followed by decarboxylation and
aldol condensation, to give an isomer of maleimycin[20]
(compound 15g) that serves as the dienophile for Diels–
Alder reaction. In support of this, the identity of com-
pound 22 was spectroscopically confirmed, andMS/MS-based
molecular networking analysis of QL37 confirmed the
presence of a mass consistent with that of the maleimycin
isomer (15g) (Supporting Information, Figure S6). The hy-
droxy-o-quinodimethane intermediate 21b is a candidate
diene reagent for the Diels–Alder reaction, which is probably
derived from the dehydration of 21a. The cycloaddition of
21b and 15g mimics the reported Diels–Alder trapping of
photochemically generated hydroxy-o-quinodimethanes by
maleimides,[21] and this intermolecular Diels–Alder reaction
Figure 3. MS2-based molecular networking of Streptomyces sp. QL37. A) Subnetwork for lugdunomycin reveals an analogue at m/z 502.
Comparison of MS2 spectra of 1 at m/z 474.151 and its analogue at m/z 502.147 suggests an additional aldehyde group in the latter; see the
fragmentation pattern above the ion peak. B) Rearranged angucyclines. The edge thickness between connecting nodes corresponds to the
similarity of the MS/MS spectra. The full GNPS network is presented in Figure S3 in the Supporting Information, and the subnetwork for non-
rearranged angucyclines in Figure S4 in the Supporting Information.
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has been explored to construct complex pseudo-natural
polyketides from simple intermediates.[22]
Genome sequencing of Streptomyces sp. QL37 allowed
the identification of a type II PKS gene cluster (lug, Support-
ing Information, Table S7 and Figure S7). Genetic inactiva-
tion of the minimal PKS genes lugA–C completely abolished
the production of angucyclines, limamycins, and lugdunomy-
cin. We are investigating the precise function of the various
genes of the lug gene cluster.
Future investigation into the genetic and synthetic knowl-
edge underlying lugdunomycin biosynthesis, will not only
guide the up-scale production of lugdunomycin and its
potential variants through synthetic biology approaches, but
will also offer new opportunities to expand the existing
Figure 4. Biosynthetic route to limamycins and proposed pathway towards lugdunomycin. A) Biosynthesis of limamycins. Baeyer–Villiger oxidative
cleavage at the quinone ring of compounds 2 and/or 6 is pivotal for the biosynthesis of lugdunomycin and rearranged limamycins 13–19.
B) Proposed pathway for lugdunomycin biosynthesis. As possible final step for the assembly of lugdunomycin a Diels–Alder reaction is proposed.
As dienophile for the Diels–Alder reaction an isomer of maleimycin (Supporting Information, Figure S6) is a likely candidate. We propose its
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structural diversity of known polyketides. Thus, our work will
likely form the basis of new explorations into the exciting
chemical space of the angucyclines and other polyketides.
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